Attached files

file filename
EX-12.1 - EXHIBIT 12.1 - SPECTRANETICS CORPex121ratioofearningstofixe.htm
10-K - 10-K - SPECTRANETICS CORPspectranetics10k12-31x2016.htm
EX-32.2 - EXHIBIT 32.2 - SPECTRANETICS CORPex32212312016.htm
EX-32.1 - EXHIBIT 32.1 - SPECTRANETICS CORPex32112312016.htm
EX-31.2 - EXHIBIT 31.2 - SPECTRANETICS CORPex31212312016.htm
EX-31.1 - EXHIBIT 31.1 - SPECTRANETICS CORPex31112312016.htm
EX-21.1 - EXHIBIT 21.1 - SPECTRANETICS CORPex211subsidiaries2016.htm
EX-10.100 - EXHIBIT 10.100 - SPECTRANETICS CORPex10100shuttonoffer.htm
EX-10.99 - EXHIBIT 10.99 - SPECTRANETICS CORPex1099amendmentno1torevo.htm


Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


The Board of Directors
The Spectranetics Corporation:

We consent to the incorporation by reference in the registration statements (Nos. 333-212347, 333-212346, 333-198980, 333-184113, 333-184112, 333-169456, 333-169455, 333-155282, 333-163507, 333-140022, and 333-145435) on Form S-8 and the registration statements (Nos. 333-196285) on Form S-3 of The Spectranetics Corporation and subsidiaries (the Company) of our report dated February 24, 2017, with respect to the consolidated balance sheets of the Company as of December 31, 2016 and 2015, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2016, and the related financial statement Schedule II - Valuation and Qualifying Accounts, and the effectiveness of internal control over financial reporting as of December 31, 2016, which report appears in the December 31, 2016 annual report on Form 10‑K of the Company.

/s/ KPMG LLP

Denver, Colorado
February 24, 2017